Esperion to grant 75,000 shares to 18 new employees
ANN ARBOR—Esperion Therapeutics Inc. (NASDAQ: ESPR), the Ann Arbor-based developer of a new class of cholesterol-reducing drugs, announced that the compensation committee of its board of directors granted non-qualified stock …